Phase 3 Respiratory Syncytial Virus (RSV) Vaccine Study

Now Enrolling

Respiratory syncytial virus (RSV) can cause infections of the lungs and respiratory tract. Symptoms can be similar to a cold, and may include runny nose, sore throat, cough, and headache. RSV can lead to serious conditions like pneumonia, especially for infants, the immunocompromised, and people age 60+.

While there is currently no approved vaccination to prevent RSV illnesses, scientists are researching an investigational vaccine for women and girls in this study.

Eligible participants…

  • Must be a female, age 10-49
  • Must not be pregnant
  • Will receive compensation for time and travel
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you or your child.

You can also talk to a Meridian enrollment specialist about this study by calling:

  • (402) 934-7563 (Lincoln)
  • (712) 639-6200 (Sioux City)
Expect Excellence icon - supporting research since 1999

Submit your information

Study Locations


  • Sioux City: Meridian Clinical Research, 4802 Sunnybrook Dr., Sioux City, IA 51106


  • Lincoln: Meridian Clinical Research, 4600 Valley Rd., Lincoln, NE 68510

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.